Department of Chemotherapy I
The Chemotherapy Department I was established in 1989 by initiative of academician J.A.Aliyev. It was the first specialized department in the country, which was constituted within oncology institution and engaged in medical therapy in malignant tumor.Today, the Chemotherapy Department I is one of leading scientific-clinical departments in the National Center of Oncology of the Ministry of Health of Azerbaijan Republic.
The main scientific research directions of department are :
- Improving existing methods of medical therapy and developing new methods.
- Clinical study of new anti-tumor drug and application in practical healthcare.
The main practical health duties are :
- Improving of drug therapy of malignant tumors.
- Preparing of qualified oncologists for peripheral oncologic institutions of the Republic and providing consultative-methodical assistance.
The Chemotherapy Department I is provided with the most modern equipments enabling to inject antitumor drugs in different time modes. Patients are provided with antitumor drugs to the extent of Free State Program.
Malignant tumors are diagnosed and treated with antitumor drugs in the department in accordance with common world standards. The department is engaged in medical therapy (chemotherapy, endocrine therapy, immunotherapy, target therapy) of patients with various localization of malignant tumors. The department cooperates with leading foreign clinics.
The most important scientific research and medical activities are as follows :
- Breast cancer : development of new aproaches as well as neoadjuvant and adjuvant therapy, target and antiangiogenic therapy in the treatment of breast cancer.
- Colon cancer : Development of new approach to the treatment of colon cancer including use of the most effective chemotherapy mode application in combination with targeted therapy for loccally advanced and methastetic colon cancer.
- Lung cancer : development of new combinated chemotheraphy+radiotheraphy in the treatment of lung cancer and application of target and antiangiogenic therapy.
- New antitumor drugs : study of new antitumor drug efficiency and acceptability in the framework of III, IV clinical research.
- Individual prognostication of treatment efficiency : The study of molecular and biological tumor marker for choosing rational treatment method.
The department is also engaged in development of new treatment approaches for ovary, stomach and other solid tumor patients. Special attention is paid to clinical use of advanced fundamental biological, genetic, immunologic sciences. Besides, special attention is paid to new methods of malignant tumors treatment, especially, target therapy development.
The department employees are highly qualified specialists experienced in leading foreign centers of medicine. Qualification of specialists and constant exchange of scientific-practice innovations with leading clinicsenable to provide the most modern drug therapy at any difficulty level in the department.
